{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:51:33Z","timestamp":1767963093268,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T00:00:00Z","timestamp":1450742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s13277-015-4603-8","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T08:49:02Z","timestamp":1450774142000},"page":"7767-7776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R"],"prefix":"10.1007","volume":"37","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lufei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manhua","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,22]]},"reference":[{"key":"4603_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"4603_CR2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-60327-492-0_20","volume":"472","author":"J Permuth-Wey","year":"2009","unstructured":"Permuth-Wey J, Sellers TA. Epidemiology of ovarian cancer. Methods Mol Biol. 2009;472:413\u201337.","journal-title":"Methods Mol Biol"},{"key":"4603_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/annonc\/mdi916","volume":"16","author":"F Legge","year":"2005","unstructured":"Legge F, Ferrandina G, Salutari V, Scambia G. Biological characterization of ovarian cancer: prognostic and therapeutic implications. Ann Oncol. 2005;16:95\u2013101.","journal-title":"Ann Oncol"},{"key":"4603_CR4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","volume":"10","author":"RL Coleman","year":"2013","unstructured":"Coleman RL, Monk BJ, Sood AK, Herzog TJ. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol. 2013;10:211\u201324.","journal-title":"Nat Rev Clin Oncol"},{"key":"4603_CR5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.gde.2005.08.005","volume":"15","author":"EA Miska","year":"2005","unstructured":"Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 2005;15:563.","journal-title":"Curr Opin Genet Dev"},{"key":"4603_CR6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V. The functions of animal microRNAs. Nature. 2004;431:350\u20135.","journal-title":"Nature"},{"key":"4603_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0092-8674(03)00231-9","volume":"113","author":"J Brennecke","year":"2003","unstructured":"Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell. 2003;113:25\u201336.","journal-title":"Cell"},{"key":"4603_CR8","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrg3471","volume":"14","author":"K Sun","year":"2013","unstructured":"Sun K, Lai EC. Adult-specific functions of animal microRNAs. Nat Rev Genet. 2013;14:535\u201348.","journal-title":"Nat Rev Genet"},{"key":"4603_CR9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrc3715","volume":"14","author":"S Seton-Rogers","year":"2014","unstructured":"Seton-Rogers S. Tumour suppressors: Hippo promotes microRNA processing. Nat Rev Cancer. 2014;14:216\u20137.","journal-title":"Nat Rev Cancer"},{"key":"4603_CR10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10555-009-9188-5","volume":"28","author":"SK Shenouda","year":"2009","unstructured":"Shenouda SK, Alahari SK. MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev. 2009;28:369\u201378.","journal-title":"Cancer Metastasis Rev"},{"key":"4603_CR11","unstructured":"Zhang X, Han C, He J: Research progress of oncogene and tumor suppressor gene in bladder cancer. Panminerva Med. 2015 (in press)."},{"key":"4603_CR12","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1182\/blood-2009-02-206706","volume":"116","author":"C Diakos","year":"2010","unstructured":"Diakos C, Zhong S, Xiao Y, Zhou M, Vasconcelos GM, Krapf G, et al. TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a. Blood. 2010;116:4885\u201393.","journal-title":"Blood"},{"key":"4603_CR13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.tiv.2009.11.013","volume":"24","author":"H Duan","year":"2010","unstructured":"Duan H, Jiang Y, Zhang H, Wu Y. MiR-320 and miR-494 affect cell cycles of primary murine bronchial epithelial cells exposed to benzo[a]pyrene. Toxicol In Vitro. 2010;24:928\u201335.","journal-title":"Toxicol In Vitro"},{"key":"4603_CR14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00381-008-0701-x","volume":"25","author":"JJ Zhao","year":"2009","unstructured":"Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, Zheng J, et al. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst. 2009;25:13\u201320.","journal-title":"Childs Nerv Syst"},{"key":"4603_CR15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3892\/or.2015.4030","volume":"34","author":"K Liu","year":"2015","unstructured":"Liu K, Liu S, Zhang W, Jia B, Tan L, Jin Z, et al. miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN. Oncol Rep. 2015;34:1003\u201310.","journal-title":"Oncol Rep"},{"key":"4603_CR16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/hep.26662","volume":"59","author":"L Lim","year":"2014","unstructured":"Lim L, Balakrishnan A, Huskey N, Jones KD, Jodari M, Ng R, et al. MicroRNA-494 within an oncogenic microRNA megacluster regulates G1\/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer. Hepatology. 2014;59:202\u201315.","journal-title":"Hepatology"},{"key":"4603_CR17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/gt.2015.39","volume":"22","author":"Y Liu","year":"2015","unstructured":"Liu Y, Li X, Zhu S, Zhang JG, Yang M, Qin Q, et al. Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc. Gene Ther. 2015;22:729\u201338.","journal-title":"Gene Ther"},{"key":"4603_CR18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/pros.22795","volume":"74","author":"PF Shen","year":"2014","unstructured":"Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q, Wei Q, et al. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer. Prostate. 2014;74:756\u201367.","journal-title":"Prostate"},{"key":"4603_CR19","doi-asserted-by":"crossref","first-page":"16570","DOI":"10.1073\/pnas.1207917109","volume":"109","author":"G Romano","year":"2012","unstructured":"Romano G, Acunzo M, Garofalo M, Di Leva G, Cascione L, Zanca C, et al. MiR-494 is regulated by ERK1\/2 and modulates trail-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc Natl Acad Sci U S A. 2012;109:16570\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4603_CR20","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1158\/1078-0432.CCR-11-0166","volume":"17","author":"WK Kim","year":"2011","unstructured":"Kim WK, Park M, Kim YK, Tae YK, Yang HK, Lee JM, et al. MicroRNA-494 downregulates kit and inhibits gastrointestinal stromal tumor cell proliferation. Clin Cancer Res. 2011;17:7584\u201394.","journal-title":"Clin Cancer Res"},{"key":"4603_CR21","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4161\/cc.21105","volume":"11","author":"S Yamanaka","year":"2012","unstructured":"Yamanaka S, Campbell NR, An F, Kuo SC, Potter JJ, Mezey E, et al. Coordinated effects of microRNA-494 induce G2\/M arrest in human cholangiocarcinoma. Cell Cycle. 2012;11:2729\u201338.","journal-title":"Cell Cycle"},{"key":"4603_CR22","first-page":"293","volume":"8","author":"YW Kim","year":"2014","unstructured":"Kim YW, Kim EY, Jeon D, Liu JL, Kim HS, Choi JW, et al. Differential microRNA expression signatures and cell type-specific association with taxol resistance in ovarian cancer cells. Drug Des Devel Ther. 2014;8:293\u2013314.","journal-title":"Drug Des Devel Ther"},{"key":"4603_CR23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1124\/mol.114.095380","volume":"87","author":"E Sanabria-Figueroa","year":"2015","unstructured":"Sanabria-Figueroa E, Donnelly SM, Foy KC, Buss MC, Castellino RC, Paplomata E, et al. Insulin-like growth factor-1 receptor signaling increases the invasive potential of human epidermal growth factor receptor 2-overexpressing breast cancer cells via Src-focal adhesion kinase and forkhead box protein M1. Mol Pharmacol. 2015;87:150\u201361.","journal-title":"Mol Pharmacol"},{"key":"4603_CR24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1757-2215-6-12","volume":"6","author":"SM King","year":"2013","unstructured":"King SM, Modi DA, Eddie SL, Burdette JE. Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathway. J Ovarian Res. 2013;6:12.","journal-title":"J Ovarian Res"},{"key":"4603_CR25","doi-asserted-by":"crossref","first-page":"10143","DOI":"10.3390\/ijms140510143","volume":"14","author":"LH Osaki","year":"2013","unstructured":"Osaki LH, Gama P. MAPKs and signal transduction in the control of gastrointestinal epithelial cell proliferation and differentiation. Int J Mol Sci. 2013;14:10143\u201361.","journal-title":"Int J Mol Sci"},{"key":"4603_CR26","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.cellsig.2007.01.028","volume":"19","author":"Z Cao","year":"2007","unstructured":"Cao Z, Liu LZ, Dixon DA, Zheng JZ, Chandran B, Jiang BH. Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells. Cell Signal. 2007;19:1542\u201353.","journal-title":"Cell Signal"},{"key":"4603_CR27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2011.11.026","volume":"317","author":"C Gest","year":"2012","unstructured":"Gest C, Mirshahi P, Li H, Pritchard LL, Joimel U, Blot E, et al. Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets. Cancer Lett. 2012;317:207\u201317.","journal-title":"Cancer Lett"},{"key":"4603_CR28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2005.09.048","volume":"100","author":"WH Gotlieb","year":"2006","unstructured":"Gotlieb WH, Bruchim I, Gu J, Shi Y, Camirand A, Blouin MJ, et al. Insulin-like growth factor receptor I targeting in epithelial ovarian cancer. Gynecol Oncol. 2006;100:389\u201396.","journal-title":"Gynecol Oncol"},{"key":"4603_CR29","first-page":"3264","volume":"59","author":"D Coppola","year":"1999","unstructured":"Coppola D, Saunders B, Fu L, Mao W, Nicosia SV. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression. Cancer Res. 1999;59:3264\u201370.","journal-title":"Cancer Res"},{"key":"4603_CR30","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.2174\/138161212800672723","volume":"18","author":"M Xue","year":"2012","unstructured":"Xue M, Cao X, Zhong Y, Kuang D, Liu X, Zhao Z, et al. Insulin-like growth factor-1 receptor (IGF1R) kinase inhibitors in cancer therapy: advances and perspectives. Curr Pharm Des. 2012;18:2901\u201313.","journal-title":"Curr Pharm Des"}],"updated-by":[{"DOI":"10.3233\/tub-219010","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"record-id":"34863"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4603-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4603-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4603-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4603-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T20:48:08Z","timestamp":1567457288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4603-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,22]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["4603"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4603-8","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,22]]}}}